Immunology
Allergy and Hypersensitivity
Introduction
 Generally the immune system is protective
 Protective mechanisms may result in severe
damages to tissues and may lead to death
When?
Severe damages may occur when the immune
system responded in exaggerated or
inappropriate form.
Classification
 Coombs and Gell classification
1-Type I - immediate ( atopic, or anaphylactic)
2-Type II - antibody-dependent
3-Type III - immune complex
4-Type IV - cell-mediated or delayed
Type I - immediate (or atopic, or anaphylactic)
 Type I hypersensitivity is an allergic reaction provoked
by re-exposure to a specific antigen.
 Exposure may be by ingestion, inhalation, injection, or
direct contact.
 The reaction is mediated by IgE antibodies and
produced by the immediate release of histamine,
tryptase, arachidonate and derivatives by basophils and
mast cells..
 This causes an inflammatory response
leading to an immediate (within seconds to
minutes) reaction.
 The reaction may be either local or systemic.
Symptoms vary from mild irritation to sudden
death from anaphylactic shock.
 Treatment usually involves epinephrine,
antihistamines, and corticosteroids
Some examples:
 Allergic asthma
 Allergic conjunctivitis
 Allergic rhinitis ("hay fever")
 Anaphylaxis
 Angioedema
 Urticaria (hives)
Type II - antibody-dependent
 In type II hypersensitivity, the antibodies produced
by the immune response bind to antigens on the
patient's own cell surfaces.
 The antigens recognized in this way may either be
intrinsic ("self" antigen, innately part of the patient's
cells) or extrinsic (absorbed onto the cells during
exposure to some foreign antigen, possibly as part
of infection with a pathogen
 IgG and IgM antibodies bind to these antigens to
form complexes that activate the classical pathway of
complement activation for eliminating cells
presenting foreign antigens (which are usually, but
not in this case, pathogens).
 As a result mediators of acute inflammation are
generated at the site and membrane attack complexes
cause cell lysis and death. The reaction takes hours
to a day.
Examples
 Autoimmune haemolytic anaemia
 Pernicious anemia
 Immune thrombocytopenia
 Transfusion reactions
 Hashimoto's thyroiditis
 Graves' disease
 Myasthenia gravis
 Farmer's Lung
 Hemolytic disease of the newborn
Type III - immune complex
In type III hypersensitivity:
 soluble immune complexes (aggregations of
antigens and IgG and IgM antibodies) form in the
blood and are deposited in various tissues
(typically the skin, kidney and joints)
 This may trigger an immune response
according to the classical pathway of
complement activation.
 The reaction takes hours to days to develop
Examples:
 Immune complex glomerulonephritis
 Rheumatoid arthritis
 Serum sickness
 Subacute bacterial endocarditis
 Symptoms of malaria
 Systemic lupus erythematosus
 Arthus reaction
Type IV Hypersensitivity
 Type IV hypersensitivity is often called
delayed type as the reaction takes two to
three days to develop.
 Unlike the other types, it is not antibody
mediated but rather is a type of cell-
mediated response.
Some clinical examples:
 Contact dermatitis (poison ivy rash, for example)
 Temporal arteritis
 Symptoms of leprosy
 Symptoms of tuberculosis
 Transplant rejection
Figure 12-2
The hypersensitivity reactions
TYPE I HYPERSENSITIVITY
 Type I hypersensitivity is also known as
immediate or anaphylactic hypersensitivity.
 The reaction may involve skin (urticaria and
eczema), eyes (conjunctivitis), nasopharynx
(rhinorrhea, rhinitis), bronchopulmonary
tissues (asthma) and gastrointestinal tract
(gastroenteritis)
 The reaction may cause a range of
symptoms from minor inconvenience to
death.
 The reaction usually takes 15 - 30 minutes
from the time of exposure to the antigen.
 sometimes it may have a delayed onset
(10 - 12 hours).
 Immediate hypersensitivity is mediated by
IgE.
 The primary cellular component in this
hypersensitivity is the mast cell or
basophil.
 The reaction is amplified and/or modified
by platelets, neutrophils and eosinophils.
 A biopsy of the reaction site demonstrates
mainly mast cells and eosinophils.
Mechanism:
 The mechanism of reaction involves preferential
production of IgE, in response to certain antigens
(allergens).
 IgE has very high affinity for its receptor on mast
cells and basophils.
 A subsequent exposure to the same allergen cross
links the cell-bound IgE and triggers the release of
various pharmacologically active substances
 Cross-linking of IgE Fc-receptor is important in mast
cell triggering. Mast cell degranulation is preceded by
increased Ca++ influx, which is a crucial process;
ionophores which increase cytoplasmic Ca++ also
promote degranulation, whereas, agents which
deplete cytoplasmic Ca++ suppress degranulation.
Fig 1
 Mast cells may be triggered by other stimuli
such as
-Exercise,
-Emotional stress
-Chemicals (e.g., photographic developing
medium, calcium ionophores, codeine, etc.),
-Anaphylotoxins (e.g., C4a, C3a, C5a, etc.).
 These reactions are not hypersensitivity
reactions although they produce the same
symptoms.
TYPE II HYPERSENSITIVITY
 Type II hypersensitivity is also known as cytotoxic
hypersensitivity and may affect a variety of organs
and tissues.
 The antigens are normally endogenous, although
exogenous chemicals (haptens) which can attach to
cell membranes can also lead to type II
hypersensitivity.
Examples:
- Drug-induced hemolytic anemia
-Granulocytopenia
-Thrombocytopenia
 The reaction time is minutes to hours.
 Type II hypersensitivity is primarily mediated
by antibodies of the IgM or IgG classes and
complement
 Phagocytes and K cells may also play a role
(ADCC).
Allergy and hypersensitivity explained in an elaborate manner
Lab Diagnosis
Diagnostic tests include detection of circulating
antibody against the tissues involved and the
presence of antibody and complement in the
lesion (biopsy) by immunofluorescence
TYPE III HYPERSENSITIVITY
 Also known as immune complex disease
 occurs when immune complex (Ag-Ab) are
not removed from circulation
 These complexes are deposited in various
tissues and organs such as:
- Kidneys
- Joints
- Lung
- Skin
 Immune complex formation may occur as
a result of :
 Autoimmune diseases (RA)
 Persistence infection (Hepatitis virus)
 Repeated inhalation of antigenic materials
MECHANISM
Step 1
Large quantities of
soluble antigen-
antibody complexes
form in the blood and
are not completely
removed by
macrophages.
Step 2
These antigen-
antibody complexes
lodge in the
capillaries between
the endothelial cells
and the basement
membrane.
Step 3
These antigen-
antibody complexes
activate the classical
complement
pathway leading to
vasodilatation.
Step 4
The complement proteins and antigen-antibody complexes
attract leukocytes to the area.
Step 5
The leukocytes
discharge their
killing agents and
promote massive
inflammation. This
can lead to tissue
death and
hemorrhage.
size of the immune complex, time, and place
determine if this reaction will occur or not
Localized depositions of immune complexes
within a tissue cause type III hypersensitivity
Allergy and hypersensitivity explained in an elaborate manner
Serum Sickness
- Is a disease caused by the injection of large doses of a
protein antigen into the blood and characterized by the
deposition of antigen-antibody complexes in blood vessel
walls, especially in the kidneys and joints.
Serum sickness
Systemic Lupus Erythmatosus
 The disease is characterized by the presence
of autoantibodies , which form immune
complexes with autoantigens and are
deposited within the kidney glomeruli
 The resulting type III hypersensitivity is
responsible for the glomerulonephritis
(Inflammation of blood capillary vessels in the
glomeruli)
TYPE IV HYPERSENSITIVITY
 Type IV hypersensitivity is also known as cell
mediated or delayed type hypersensitivity.
 The classical example of this hypersensitivity
is tuberculin (Montoux) reaction
 Reaction peaks 48 hours after the injection of
antigen (PPD or old tuberculin). The lesion is
characterized by induration and erythema
Allergy and hypersensitivity explained in an elaborate manner
 Type IV hypersensitivity is involved in the
pathogenesis of many autoimmune and infectious
diseases:
 Tuberculosis
 Leprosy
 Blastomycosis
 Histoplasmosis
 Toxoplasmosis
 Leishmaniasis
 Granulomas due to infections and foreign antigens.
Allergy and hypersensitivity explained in an elaborate manner
 Another form of delayed hypersensitivity is
contact dermatitis (poison ivy (figure 6),
chemicals, heavy metals, etc.) in which the
lesions are more papular
 Type IV hypersensitivity can be classified into
three categories depending on the time of
onset and clinical and histological
presentation
Fig 5
Type
Reaction
time
Clinical
appearance
Histology Antigen and site
contact 48-72 hr eczema
lymphocytes, followed by
macrophages; edema of
epidermis
epidermal ( organic chemicals,
poison ivy, heavy metals,
etc.)
tuberculin 48-72 hr
local
induratio
lymphocytes, monocytes,
macrophages
intradermal (tuberculin, lepromin,
etc.)
granuloma 21-28 days hardening
macrophages, epitheloid and
giant cells, fibrosis
persistent antigen or foreign
body presence
(tuberculosis, leprosy, etc.)
Mechanism:
 The mechanism includes T lymphocytes and
monocytes and/or macrophages.
 Cytotoxic T cells (Tc) cause direct damage
whereas helper T (TH1) cells secrete
cytokines which activate cytotoxic T cells,
recruit and activate monocytes and
macrophages, which cause the bulk of the
damage
 The delayed hypersensitivity lesions mainly
contain monocytes and a few T cells.
Diagnosis
 Diagnostic tests in vivo include delayed
cutaneous reaction (e.g. Montoux test )
 In vitro tests for delayed hypersensitivity
include mitogenic response, lympho-
cytotoxicity and IL-2 production.
 Corticosteroids & other immunosuppressive
agents are used in treatment.

More Related Content

PPTX
hypersensitivity-161227093835.pptx
PPT
Hypersensitivity
PPTX
Hypersensitivity
PPTX
hypersensitivity
PDF
Hypersensitivity.pdf
PDF
allergyandhypersensitivity-200825071133.pdf
PPTX
PPTX
HYPERSENSITIVITY
hypersensitivity-161227093835.pptx
Hypersensitivity
Hypersensitivity
hypersensitivity
Hypersensitivity.pdf
allergyandhypersensitivity-200825071133.pdf
HYPERSENSITIVITY

Similar to Allergy and hypersensitivity explained in an elaborate manner (20)

PPTX
Gell and coombs classification
PPTX
Hypersensitivity PPT
PPTX
Hypersensitivity
PPTX
Naseem Khan Immunogy HYPERSENSITIVITY-WPS Office.pptx
PPTX
Share_Hypersensitivity reactions-WPS_Office.pptx
PDF
Hypersensitivity Update .pdf Immunology and Micro
PPTX
Hypersensitivity. immunology and microbiology course
PPTX
TYPES AND MECHANISM OF HYPERSENSITIVITY REACTIONS.pptx
PDF
Hypersensitivity reactions
DOCX
Hypersensitivity
PPTX
HYPERSENSITIVITY REACTIONS PATHOLOGY1.pptx
PPTX
5 immunopathology.pptx
PDF
00 micro hypersensitivity.pdf
PPTX
Hypersensitivity Reactions hematologic system
PDF
5-Hypersensitivity. immunology course department of pathology
PDF
Hypersensitivity
PPTX
Diseases of immunity hypersensitivity
PPT
Hypersensitivity.ppt
PPTX
Hypersensitivity reactions
PPTX
HYPERSENSITIVITY REACTIONS path and micropptx
Gell and coombs classification
Hypersensitivity PPT
Hypersensitivity
Naseem Khan Immunogy HYPERSENSITIVITY-WPS Office.pptx
Share_Hypersensitivity reactions-WPS_Office.pptx
Hypersensitivity Update .pdf Immunology and Micro
Hypersensitivity. immunology and microbiology course
TYPES AND MECHANISM OF HYPERSENSITIVITY REACTIONS.pptx
Hypersensitivity reactions
Hypersensitivity
HYPERSENSITIVITY REACTIONS PATHOLOGY1.pptx
5 immunopathology.pptx
00 micro hypersensitivity.pdf
Hypersensitivity Reactions hematologic system
5-Hypersensitivity. immunology course department of pathology
Hypersensitivity
Diseases of immunity hypersensitivity
Hypersensitivity.ppt
Hypersensitivity reactions
HYPERSENSITIVITY REACTIONS path and micropptx
Ad

Recently uploaded (20)

PDF
English Textual Question & Ans (12th Class).pdf
PPTX
Unit 4 Computer Architecture Multicore Processor.pptx
PDF
International_Financial_Reporting_Standa.pdf
PDF
CISA (Certified Information Systems Auditor) Domain-Wise Summary.pdf
PDF
BP 505 T. PHARMACEUTICAL JURISPRUDENCE (UNIT 2).pdf
PDF
LIFE & LIVING TRILOGY - PART (3) REALITY & MYSTERY.pdf
PPTX
Introduction to pro and eukaryotes and differences.pptx
PDF
Journal of Dental Science - UDMY (2021).pdf
PPTX
Module on health assessment of CHN. pptx
PDF
Complications of Minimal Access-Surgery.pdf
PDF
IP : I ; Unit I : Preformulation Studies
PPTX
What’s under the hood: Parsing standardized learning content for AI
DOCX
Cambridge-Practice-Tests-for-IELTS-12.docx
PPTX
Share_Module_2_Power_conflict_and_negotiation.pptx
PDF
Myanmar Dental Journal, The Journal of the Myanmar Dental Association (2013).pdf
PDF
Race Reva University – Shaping Future Leaders in Artificial Intelligence
PDF
LEARNERS WITH ADDITIONAL NEEDS ProfEd Topic
PDF
Empowerment Technology for Senior High School Guide
PDF
David L Page_DCI Research Study Journey_how Methodology can inform one's prac...
PDF
HVAC Specification 2024 according to central public works department
English Textual Question & Ans (12th Class).pdf
Unit 4 Computer Architecture Multicore Processor.pptx
International_Financial_Reporting_Standa.pdf
CISA (Certified Information Systems Auditor) Domain-Wise Summary.pdf
BP 505 T. PHARMACEUTICAL JURISPRUDENCE (UNIT 2).pdf
LIFE & LIVING TRILOGY - PART (3) REALITY & MYSTERY.pdf
Introduction to pro and eukaryotes and differences.pptx
Journal of Dental Science - UDMY (2021).pdf
Module on health assessment of CHN. pptx
Complications of Minimal Access-Surgery.pdf
IP : I ; Unit I : Preformulation Studies
What’s under the hood: Parsing standardized learning content for AI
Cambridge-Practice-Tests-for-IELTS-12.docx
Share_Module_2_Power_conflict_and_negotiation.pptx
Myanmar Dental Journal, The Journal of the Myanmar Dental Association (2013).pdf
Race Reva University – Shaping Future Leaders in Artificial Intelligence
LEARNERS WITH ADDITIONAL NEEDS ProfEd Topic
Empowerment Technology for Senior High School Guide
David L Page_DCI Research Study Journey_how Methodology can inform one's prac...
HVAC Specification 2024 according to central public works department
Ad

Allergy and hypersensitivity explained in an elaborate manner

  • 2. Introduction  Generally the immune system is protective  Protective mechanisms may result in severe damages to tissues and may lead to death When? Severe damages may occur when the immune system responded in exaggerated or inappropriate form.
  • 3. Classification  Coombs and Gell classification 1-Type I - immediate ( atopic, or anaphylactic) 2-Type II - antibody-dependent 3-Type III - immune complex 4-Type IV - cell-mediated or delayed
  • 4. Type I - immediate (or atopic, or anaphylactic)  Type I hypersensitivity is an allergic reaction provoked by re-exposure to a specific antigen.  Exposure may be by ingestion, inhalation, injection, or direct contact.  The reaction is mediated by IgE antibodies and produced by the immediate release of histamine, tryptase, arachidonate and derivatives by basophils and mast cells..
  • 5.  This causes an inflammatory response leading to an immediate (within seconds to minutes) reaction.  The reaction may be either local or systemic. Symptoms vary from mild irritation to sudden death from anaphylactic shock.  Treatment usually involves epinephrine, antihistamines, and corticosteroids
  • 6. Some examples:  Allergic asthma  Allergic conjunctivitis  Allergic rhinitis ("hay fever")  Anaphylaxis  Angioedema  Urticaria (hives)
  • 7. Type II - antibody-dependent  In type II hypersensitivity, the antibodies produced by the immune response bind to antigens on the patient's own cell surfaces.  The antigens recognized in this way may either be intrinsic ("self" antigen, innately part of the patient's cells) or extrinsic (absorbed onto the cells during exposure to some foreign antigen, possibly as part of infection with a pathogen
  • 8.  IgG and IgM antibodies bind to these antigens to form complexes that activate the classical pathway of complement activation for eliminating cells presenting foreign antigens (which are usually, but not in this case, pathogens).  As a result mediators of acute inflammation are generated at the site and membrane attack complexes cause cell lysis and death. The reaction takes hours to a day.
  • 9. Examples  Autoimmune haemolytic anaemia  Pernicious anemia  Immune thrombocytopenia  Transfusion reactions  Hashimoto's thyroiditis  Graves' disease  Myasthenia gravis  Farmer's Lung  Hemolytic disease of the newborn
  • 10. Type III - immune complex In type III hypersensitivity:  soluble immune complexes (aggregations of antigens and IgG and IgM antibodies) form in the blood and are deposited in various tissues (typically the skin, kidney and joints)  This may trigger an immune response according to the classical pathway of complement activation.  The reaction takes hours to days to develop
  • 11. Examples:  Immune complex glomerulonephritis  Rheumatoid arthritis  Serum sickness  Subacute bacterial endocarditis  Symptoms of malaria  Systemic lupus erythematosus  Arthus reaction
  • 12. Type IV Hypersensitivity  Type IV hypersensitivity is often called delayed type as the reaction takes two to three days to develop.  Unlike the other types, it is not antibody mediated but rather is a type of cell- mediated response.
  • 13. Some clinical examples:  Contact dermatitis (poison ivy rash, for example)  Temporal arteritis  Symptoms of leprosy  Symptoms of tuberculosis  Transplant rejection
  • 16.  Type I hypersensitivity is also known as immediate or anaphylactic hypersensitivity.  The reaction may involve skin (urticaria and eczema), eyes (conjunctivitis), nasopharynx (rhinorrhea, rhinitis), bronchopulmonary tissues (asthma) and gastrointestinal tract (gastroenteritis)
  • 17.  The reaction may cause a range of symptoms from minor inconvenience to death.  The reaction usually takes 15 - 30 minutes from the time of exposure to the antigen.  sometimes it may have a delayed onset (10 - 12 hours).
  • 18.  Immediate hypersensitivity is mediated by IgE.  The primary cellular component in this hypersensitivity is the mast cell or basophil.  The reaction is amplified and/or modified by platelets, neutrophils and eosinophils.  A biopsy of the reaction site demonstrates mainly mast cells and eosinophils.
  • 19. Mechanism:  The mechanism of reaction involves preferential production of IgE, in response to certain antigens (allergens).  IgE has very high affinity for its receptor on mast cells and basophils.  A subsequent exposure to the same allergen cross links the cell-bound IgE and triggers the release of various pharmacologically active substances  Cross-linking of IgE Fc-receptor is important in mast cell triggering. Mast cell degranulation is preceded by increased Ca++ influx, which is a crucial process; ionophores which increase cytoplasmic Ca++ also promote degranulation, whereas, agents which deplete cytoplasmic Ca++ suppress degranulation.
  • 20. Fig 1
  • 21.  Mast cells may be triggered by other stimuli such as -Exercise, -Emotional stress -Chemicals (e.g., photographic developing medium, calcium ionophores, codeine, etc.), -Anaphylotoxins (e.g., C4a, C3a, C5a, etc.).  These reactions are not hypersensitivity reactions although they produce the same symptoms.
  • 23.  Type II hypersensitivity is also known as cytotoxic hypersensitivity and may affect a variety of organs and tissues.  The antigens are normally endogenous, although exogenous chemicals (haptens) which can attach to cell membranes can also lead to type II hypersensitivity. Examples: - Drug-induced hemolytic anemia -Granulocytopenia -Thrombocytopenia
  • 24.  The reaction time is minutes to hours.  Type II hypersensitivity is primarily mediated by antibodies of the IgM or IgG classes and complement  Phagocytes and K cells may also play a role (ADCC).
  • 26. Lab Diagnosis Diagnostic tests include detection of circulating antibody against the tissues involved and the presence of antibody and complement in the lesion (biopsy) by immunofluorescence
  • 28.  Also known as immune complex disease  occurs when immune complex (Ag-Ab) are not removed from circulation  These complexes are deposited in various tissues and organs such as: - Kidneys - Joints - Lung - Skin
  • 29.  Immune complex formation may occur as a result of :  Autoimmune diseases (RA)  Persistence infection (Hepatitis virus)  Repeated inhalation of antigenic materials
  • 30. MECHANISM Step 1 Large quantities of soluble antigen- antibody complexes form in the blood and are not completely removed by macrophages.
  • 31. Step 2 These antigen- antibody complexes lodge in the capillaries between the endothelial cells and the basement membrane.
  • 32. Step 3 These antigen- antibody complexes activate the classical complement pathway leading to vasodilatation.
  • 33. Step 4 The complement proteins and antigen-antibody complexes attract leukocytes to the area.
  • 34. Step 5 The leukocytes discharge their killing agents and promote massive inflammation. This can lead to tissue death and hemorrhage.
  • 35. size of the immune complex, time, and place determine if this reaction will occur or not
  • 36. Localized depositions of immune complexes within a tissue cause type III hypersensitivity
  • 38. Serum Sickness - Is a disease caused by the injection of large doses of a protein antigen into the blood and characterized by the deposition of antigen-antibody complexes in blood vessel walls, especially in the kidneys and joints.
  • 40. Systemic Lupus Erythmatosus  The disease is characterized by the presence of autoantibodies , which form immune complexes with autoantigens and are deposited within the kidney glomeruli  The resulting type III hypersensitivity is responsible for the glomerulonephritis (Inflammation of blood capillary vessels in the glomeruli)
  • 42.  Type IV hypersensitivity is also known as cell mediated or delayed type hypersensitivity.  The classical example of this hypersensitivity is tuberculin (Montoux) reaction  Reaction peaks 48 hours after the injection of antigen (PPD or old tuberculin). The lesion is characterized by induration and erythema
  • 44.  Type IV hypersensitivity is involved in the pathogenesis of many autoimmune and infectious diseases:  Tuberculosis  Leprosy  Blastomycosis  Histoplasmosis  Toxoplasmosis  Leishmaniasis  Granulomas due to infections and foreign antigens.
  • 46.  Another form of delayed hypersensitivity is contact dermatitis (poison ivy (figure 6), chemicals, heavy metals, etc.) in which the lesions are more papular  Type IV hypersensitivity can be classified into three categories depending on the time of onset and clinical and histological presentation
  • 47. Fig 5 Type Reaction time Clinical appearance Histology Antigen and site contact 48-72 hr eczema lymphocytes, followed by macrophages; edema of epidermis epidermal ( organic chemicals, poison ivy, heavy metals, etc.) tuberculin 48-72 hr local induratio lymphocytes, monocytes, macrophages intradermal (tuberculin, lepromin, etc.) granuloma 21-28 days hardening macrophages, epitheloid and giant cells, fibrosis persistent antigen or foreign body presence (tuberculosis, leprosy, etc.)
  • 48. Mechanism:  The mechanism includes T lymphocytes and monocytes and/or macrophages.  Cytotoxic T cells (Tc) cause direct damage whereas helper T (TH1) cells secrete cytokines which activate cytotoxic T cells, recruit and activate monocytes and macrophages, which cause the bulk of the damage  The delayed hypersensitivity lesions mainly contain monocytes and a few T cells.
  • 49. Diagnosis  Diagnostic tests in vivo include delayed cutaneous reaction (e.g. Montoux test )  In vitro tests for delayed hypersensitivity include mitogenic response, lympho- cytotoxicity and IL-2 production.  Corticosteroids & other immunosuppressive agents are used in treatment.

Editor's Notes

  • #38: Figure 12.20. Serum sickness is a classic example of a transient immune complex-mediated syndrome. An injection of a foreign protein or proteins leads to an antibody response. These antibodies form immune complexes with the circulating foreign proteins. The complexes are deposited in small vessels and activate complement and phagocytes, inducing fever and the symptoms of vasculitis, nephritis, and arthritis. All these effects are transient and resolve when the foreign protein is cleared.